HeyJaredKaylea Swearingen
- Indexed articles, last 90 days
- 2
- Latest publication
- Sep 15, 2026
- Outlet visibility, for Healthline
- Top 5K sites
- Earliest in this view
- Jul 27, 2026
Latest articles
Comparison of Ozempic and Non-GLP-1 Peptides (opens the original)
Read excerpt
In recent years, peptide therapies have reshaped the landscape of weight management and metabolic health. But not all peptides are created equal. Some peptides, including GLP-1s such as Ozempic, have been rigorously studied in trials and approved by the Food and Drug Administration (FDA). Others are experimental or investigational compounds that are still being studied. But what are the differences between GLP-1 medications and non-GLP-1 peptides for weight loss? Yes, Ozempic is a peptide. It is
The Truth About GLP-3s (opens the original)
Read excerpt
A new generation of anti-obesity and diabetes medications is stepping into the spotlight â âGLP-3sâ. Following the development of effective single- and dual-receptor therapies, research is turning its attention to a new class of compounds commonly referred to as âGLP-3sâ or triple-hormone receptor agonists. GLP-1s, such as semaglutide (Wegovy), target a single hormone pathway â glucagon-like peptide-1 (GLP-1) â to slow gastric emptying, lower blood sugar, and reduce appetite. Dual
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5K sites
For Healthline, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.